Paper9109501
Cell cycle and cancer: critical events at the G1 restriction point.
DelSal G and 2 others. Crit Rev Oncog, 1996. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Cell cycle and cancer: critical events at the G1 restriction point. Papers, record 9109501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9109501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| G1 Phase | Major topic |
| Neoplasms | Major topic |
| Cyclin-Dependent Kinases | |
| Humans | |
| S Phase |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30258182 | The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30258182 | PubMed |
| 29137415 | Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation. | Oncotarget | 2017 | https://conductscience.org/library/papers/29137415 | PubMed |
| 26733491 | The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells. | Oncotarget | 2015 | https://conductscience.org/library/papers/26733491 | PubMed |
| 24520316 | CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cells. | PLoS One | 2014 | https://conductscience.org/library/papers/24520316 | PubMed |
| 24037419 | Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells. | Int J Hematol | 2013 | https://conductscience.org/library/papers/24037419 | PubMed |
| 20661828 | Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice. | Nutr Cancer | 2010 | https://conductscience.org/library/papers/20661828 | PubMed |
| 15208676 | ERbeta exerts multiple stimulative effects on human breast carcinoma cells. | Oncogene | 2004 | https://conductscience.org/library/papers/15208676 | PubMed |
| 10995786 | Role of the Cdc25A phosphatase in human breast cancer. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10995786 | PubMed |
| 10982843 | SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10982843 | PubMed |
| 10698498 | v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts. | Oncogene | 2000 | https://conductscience.org/library/papers/10698498 | PubMed |
| 10669755 | Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10669755 | PubMed |
| 10665481 | Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. | Invest New Drugs | 1999 | https://conductscience.org/library/papers/10665481 | PubMed |
| 10550307 | p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis. | Am J Pathol | 1999 | https://conductscience.org/library/papers/10550307 | PubMed |
| 10514396 | Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. | Am J Pathol | 1999 | https://conductscience.org/library/papers/10514396 | PubMed |
| 9736017 | Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. | Am J Pathol | 1998 | https://conductscience.org/library/papers/9736017 | PubMed |
| 9694794 | Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. | Genes Dev | 1998 | https://conductscience.org/library/papers/9694794 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CHKA | 1119 | PubTator's text mining | https://conductscience.org/library/genes/1119 | NCBI Gene |
| PCNA | 5111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9109501
GET https://conductscience.org/api/papers/v1/9109501/authors